Salgia, Ravi
Weaver, R. Waide
McCleod, Michael
Stille, John R.
Yan, S. Betty
Roberson, Stephanie
Polzer, John
Flynt, Amy
Raddad, Eyas
Peek, Victoria L.
Wijayawardana, Sameera R.
Um, Suzane L.
Gross, Steve
Connelly, Mark C.
Morano, Carrie
Repollet, Madeline
Sanders, Renouard
Baeten, Kurt
D’Haese, David
Spigel, David R.
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 19 December 2016
Accepted: 23 February 2017
First Online: 15 March 2017
Compliance with ethical standards
:
: J.R. Stille, S.B. Yan, S. Roberson, J. Polzer, E. Raddad, V.L. Peek, S.R. Wijayawardana, and S.L. Um are employees and shareholders of Eli Lilly and Company.S. Gross, M.C. Connelly, C. Morano, M. Repollet, R. Sanders, K. Baeten, and D. D’Haese are employees of Janssen Diagnostics and shareholders of Johnson and Johnson Company.S. Gross and C. Morano receive royalties from Johnson and Johnson Company.D.R. Spigel receives no compensation as an advisor to Bristol-Myers Squibb, Genentech/Roche, Novartis, and Pfizer and serves on a data safety monitoring board for Merck.No conflict of interest was reported by R. Salgia, M. McCleod, R.W. Weaver, or A. Flynt.
: This study was funded by Eli Lilly and Company.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study. The informed consent form was signed by the patient and physician prior to study procedures in accordance with International Conference on Harmonization guidelines on Good Clinical Practice.